CONTINUING MEDICAL EDUCATION (CME) QUESTIONS|
June 15, 2023
Abatacept in steroid-refractory cGVHD
CME
Blood (2023) 141 (24): 3008.
Connected Content
A related article has been published:
Phase 2 clinical trial evaluating abatacept in patients with steroid-refractory chronic graft-versus-host disease
Citation
Abatacept in steroid-refractory cGVHD. Blood 2023; 141 (24): 3008. doi: https://doi.org/10.1182/blood.2023021044
Download citation file: